GlassScriptPhysician profile
John James Verre
NPI 1013336577
$4,479.41
in general payments reported to CMS, 2019-2025
18 companies · $444 in 2025
The $444 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,554 · 2020: $314 · 2021: $616 · 2022: $152 · 2023: $169 · 2024: $230 · 2025: $444.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $843.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $842.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,601.36 | 2019-2024 | Mako |
| Medical Device Business Services, INC. | $840.34 | 2019 | |
| Depuy Synthes Sales INC. | $688.17 | 2019-2025 | Na, Va-Lcp, Fibergraft Aeridyan Matrix |
| Smith+Nephew, INC. | $270.87 | 2021-2025 | Real Intelligence, Pico 14 |
| Zimmer Biomet Holdings, INC. | $267.72 | 2020-2021 | |
| Linvatec Corporation | $163.61 | 2025 | Linvatec Shoulder Arthroscopy, Biobrace 23mm |
| Si-Bone, INC. | $133.22 | 2020-2021 | |
| Convatec INC. | $92.79 | 2019 | |
| True North Surgical INC | $85.56 | 2022 | |
| Arthrex, INC. | $73.32 | 2021 | |
| Checkpoint Surgical, INC | $54.28 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $48.26 | 2022-2025 | Exparel |
| Pfizer INC. | $45.27 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $41.36 | 2025 | |
| Ferring Pharmaceuticals INC. | $23.85 | 2024 | Euflexxa |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $23.24 | 2022 | |
| Kci USA, INC. | $14.31 | 2020 | |
| Bioventus LLC | $11.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Verre listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.